〇Akira Sobue1,2, Okiru Komine1, Yuichiro Hara3,4, Fumito Endo1, Hiroyuki Mizoguchi5, Seiji Watanabe1, Shigeo Murayama6,7, Takashi Saito8, Takaomi Saido9, Naruhiko Sahara10, Makoto Higuchi10, Tomoo Ogi3, Koji Yamanaka1
(1.Dept of Neurosci and Pathobiol, Res. Inst. of Environmental Medicine, Nagoya Univ., 2.Medical Interactive Research and Academia Industry Collaboration Center, Res. Inst. of Environmental Medicine, Nagoya Univ., 3.Dept of Genetics, Res. Inst. of Environmental Medicine, Nagoya Univ., 4.Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science., 5.Dept of Neuropsychopharm. and Hospital Pharmacy, Nagoya University Graduate School of Medicine., 6.Dept of Neuropathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology., 7.Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka Univ., 8.Dept of Neurocognitive Sci, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences., 9.Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science., 10.Dept of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology.)
Keywords:Microglia, Alzheimer's disease, neuroinflammation